PLCG2 and autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation: The S707Y PLCγ2 mutation disrupts the autoinhibition of PLCγ2, thereby increasing PLCγ2 activity and calcium influx from the ER in the leukocytes of patients with APLAID [106, 107].